Geoff Noller
Overview
Explore the profile of Geoff Noller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Potter S, Noller G, Pillay L, Crossin R
N Z Med J
. 2025 Mar;
138(1611):65-78.
PMID: 40080762
Aim: People who inject drugs (PWID) are at risk of injecting-related injuries and diseases (IRIDs), but little is known about these in Aotearoa. We aimed to characterise the impact of...
2.
Al-Busaidi I, Noller G, Ross J, Gray A, Peterson A, Aldabe D, et al.
Health Sci Rep
. 2024 Nov;
7(11):e70190.
PMID: 39512252
Background And Aims: Previous studies describe the occurrence of unacceptable behaviors reported by students pursuing health professional education in Aotearoa, New Zealand and across the globe. These include, but are...
3.
Whelan J, Ward R, Noller G
Harm Reduct J
. 2024 May;
21(1):100.
PMID: 38783300
Background: Methylenedioxymethamphetamine (MDMA) is a popular drug worldwide and use is prevalent in Aotearoa New Zealand. Although associated with some significant harms, including fatalities, MDMA is ultimately less harmful than...
4.
Whelan J, Noller G, Ward R
Harm Reduct J
. 2024 Mar;
21(1):67.
PMID: 38515184
Background: 3,4-Methylenedioxymethamphetamine (MDMA) is drug of high prevalence in Aotearoa New Zealand and is the primary drug analysed by legal drug checking services. We aimed to address the gap in...
5.
Crossin R, Cleland L, Wilkins C, Rychert M, Adamson S, Potiki T, et al.
J Psychopharmacol
. 2023 Jun;
37(9):891-903.
PMID: 37353972
Aims: The harms arising from psychoactive drug use are complex, and harm reduction strategies should be informed by a detailed understanding of the extent and nature of that harm. Drug...
6.
Doolan-Noble F, Noller G, Nixon G, Stokes T
Rural Remote Health
. 2021 Mar;
21(1):5659.
PMID: 33751896
Introduction: The use of implantable cardioverter defibrillators (ICDs) is increasing in both New Zealand and Australia. Also, both countries are experiencing an ageing of their rural populations. Much of the...
7.
Armour M, Sinclair J, Noller G, Girling J, Larcombe M, Al-Dabbas M, et al.
J Womens Health (Larchmt)
. 2020 Dec;
30(10):1485-1492.
PMID: 33275491
Endometriosis affects around 10% of women worldwide. Many women with endometriosis struggle with finding adequate pain management, and data from other countries suggest that women use cannabis, either legal or...
8.
Noller G, Bourke J
N Z Med J
. 2020 Nov;
133(1525):84-95.
PMID: 33223551
Aim: The study's principal aim was to ascertain the viability of point-of-care rapid testing for hepatitis C (HCV) antibodies by non-clinician frontline peer needle exchange staff. Secondary aims included identifying...
9.
Richard L, Noller G, Derrett S, Sullivan T, Doolan-Noble F, McCombie A, et al.
BMJ Open
. 2020 Nov;
10(11):e041789.
PMID: 33184085
Objective: To explore how adults living with inflammatory bowel disease (IBD) in rural New Zealand manage their condition and engage with healthcare providers. Design: Qualitative exploratory design with semi-structured interviews...
10.
Jaye C, Noller G, Richard L, Amos C
Anthropol Med
. 2020 Sep;
28(4):461-476.
PMID: 32981340
This paper examines the role of sick leave in constructing the identity of a good worker. The setting is a public funded New Zealand university. Within a qualitative research design,...